Guangnan Wei

413 total citations
11 papers, 209 citations indexed

About

Guangnan Wei is a scholar working on Oncology, Cancer Research and Molecular Biology. According to data from OpenAlex, Guangnan Wei has authored 11 papers receiving a total of 209 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 7 papers in Cancer Research and 5 papers in Molecular Biology. Recurrent topics in Guangnan Wei's work include Cancer Genomics and Diagnostics (5 papers), Advanced Breast Cancer Therapies (3 papers) and BRCA gene mutations in cancer (2 papers). Guangnan Wei is often cited by papers focused on Cancer Genomics and Diagnostics (5 papers), Advanced Breast Cancer Therapies (3 papers) and BRCA gene mutations in cancer (2 papers). Guangnan Wei collaborates with scholars based in China and United States. Guangnan Wei's co-authors include Guochun Zhang, Yulei Wang, Bo Chen, Lingzhu Wen, Li Cao, Minghan Jia, Cheukfai Li, Hsiaopei Mok, Chongyang Ren and Jiali Lin and has published in prestigious journals such as Gene, BMC Medicine and Frontiers in Oncology.

In The Last Decade

Guangnan Wei

11 papers receiving 207 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Guangnan Wei China	6	127	97	71	59	39	11	209
Carina Forsare Sweden	10	139 1.1×	111 1.1×	89 1.3×	76 1.3×	10 0.3×	14	272
Claudette Falato Spain	10	161 1.3×	107 1.1×	78 1.1×	78 1.3×	25 0.6×	20	261
Arielle J. Medford United States	8	139 1.1×	98 1.0×	50 0.7×	88 1.5×	38 1.0×	44	247
Lillian M. Smyth United States	7	92 0.7×	62 0.6×	39 0.5×	46 0.8×	28 0.7×	24	166
Jean‐Christophe Théry France	6	129 1.0×	94 1.0×	48 0.7×	69 1.2×	31 0.8×	10	184
Pablo Tolosa Spain	8	154 1.2×	50 0.5×	61 0.9×	91 1.5×	30 0.8×	36	229
Danai Fimereli Belgium	7	211 1.7×	140 1.4×	63 0.9×	67 1.1×	81 2.1×	10	294
Giulia Cursano Italy	9	102 0.8×	87 0.9×	65 0.9×	49 0.8×	43 1.1×	14	192
Xiangyu Zhao China	7	55 0.4×	88 0.9×	109 1.5×	42 0.7×	25 0.6×	20	186
Dechuang Jiao China	11	125 1.0×	139 1.4×	115 1.6×	39 0.7×	17 0.4×	30	263

Countries citing papers authored by Guangnan Wei

Since Specialization

Citations

This map shows the geographic impact of Guangnan Wei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guangnan Wei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guangnan Wei more than expected).

Fields of papers citing papers by Guangnan Wei

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guangnan Wei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guangnan Wei. The network helps show where Guangnan Wei may publish in the future.

Co-authorship network of co-authors of Guangnan Wei

This figure shows the co-authorship network connecting the top 25 collaborators of Guangnan Wei. A scholar is included among the top collaborators of Guangnan Wei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guangnan Wei. Guangnan Wei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

Cao, Li, Chongyang Ren, Guochun Zhang, et al.. (2022). Characteristics of MYC Amplification and Their Association with Clinicopathological and Molecular Factors in Patients with Breast Cancer. DNA and Cell Biology. 41(5). 521–538. 5 indexed citations

Zhang, Guochun, Chongyang Ren, Cheukfai Li, et al.. (2022). Distinct clinical and somatic mutational features of breast tumors with high-, low-, or non-expressing human epidermal growth factor receptor 2 status. BMC Medicine. 20(1). 142–142. 90 indexed citations

Li, Kai, Li Cao, Cheukfai Li, et al.. (2022). Genomic alteration profile and PD‐L1 expression among different breast cancer subtypes in Chinese population and their correlations. Cancer Medicine. 12(5). 5195–5208. 2 indexed citations

Jia, Minghan, Ning Liao, Bo Chen, et al.. (2021). PIK3CA somatic alterations in invasive breast cancers: different spectrum from Caucasians to Chinese detected by next generation sequencing. Breast Cancer. 28(3). 644–652. 8 indexed citations

Wen, Lingzhu, Guochun Zhang, Chongyang Ren, et al.. (2021). Characterization of AKT Somatic Mutations in Chinese Breast Cancer Patients. Cancer Management and Research. Volume 13. 3055–3065. 5 indexed citations

Chen, Bo, Liping Guo, Kai Li, et al.. (2021). Association of Body Mass Index With Somatic Mutations in Breast Cancer. Frontiers in Oncology. 11. 613933–613933. 1 indexed citations

Chen, Bo, Guochun Zhang, Guangnan Wei, et al.. (2020). Heterogeneity of genomic profile in patients with HER2-positive breast cancer. Endocrine Related Cancer. 27(3). 153–162. 26 indexed citations

Guo, Liping, Bo Chen, Guochun Zhang, et al.. (2020). The transcription factor CBFB mutations indicate an improved survival in HR+/HER2- breast cancer. Gene. 759. 144970–144970. 3 indexed citations

Chen, Bo, Jianguo Lai, Liping Guo, et al.. (2020). Adverse effects of being underweight on young female breast cancer patients with lymph node metastases. Journal of Cancer. 11(7). 1976–1984. 10 indexed citations

10.

Chen, Bo, Guochun Zhang, Xuerui Li, et al.. (2020). Comparison of BRCA versus non-BRCA germline mutations and associated somatic mutation profiles in patients with unselected breast cancer. Aging. 12(4). 3140–3155. 36 indexed citations

11.

Wang, Yulei, Wenzhen Zhu, Xiaohong Chen, et al.. (2020). Selenium-binding protein 1 transcriptionally activates p21 expression via p53-independent mechanism and its frequent reduction associates with poor prognosis in bladder cancer. Journal of Translational Medicine. 18(1). 17–17. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact